Skip to main content
SpringerLink
Log in

The GG genotype of the −152 G/A vascular endothelial growth factor (VEGF) polymorphism predisposes to hypertension-related chronic kidney disease

  • Original Article
  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Our purpose was to determine whether the VEGF −152 G/A polymorphism could be associated with chronic kidney disease and endothelial dysfunction in hypertensive patients. There were 100 healthy volunteers enrolled into the control group. The group of patients was constituted by 99 consecutively admitted hypertensive patients referred to our Institution by their general practitioner. All patients were treated with anti-hypertensive polytherapy. Presented study revealed that the hypertensive patients bearing the GG genotype were characterized by the highest values of diastolic blood pressure and markers of endothelial damage such as Angiogenin, Endostatin, CRP as well as von Willebrandt factor. In addition, higher number of immature endothelial progenitor cells with CD34+CD133+, CD34+CD133- markers was observed in GG hypertensive carriers while in normotensive individuals no differences were found. Such phenomenon may indicate an increased mobilization of bone-marrow derived endothelial progenitors. It may testify to the preserved compensatory mechanism in chronic kidney disease (CKD) patients until the G3a stage of the disease. Moreover, patients with higher estimated glomerular filtration rate (eGFR) level had lower of vWf and Endostatin values, and higher level of VEGF. Taken together our findings clearly indicate the −152 GG hypertensive carriers as more prone to develop CKD. We can suspect that the VEGF −152 GG genotype is strongly associated with hypertension-dependent CKD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Noble LE, Ferdinand AC, Stassen Frank RM, Hacking Wim JG, Boudier Struijker Harry AJ (1998) Angiogenesis and hypertension. J Hypertens 16:1563–1572

    Article  PubMed  Google Scholar 

  2. Antonios TF, Singer DR, Markandu ND, Mortimer PS, MacGregor GA (1999) Rarefaction of skin capillaries in borderline essential hypertension suggests an early structural abnormality. Hypertension 34:655–658

    Article  CAS  PubMed  Google Scholar 

  3. Ciuffetti G, Pasqualini L, Pirro M, Lombardini R, De Sio M, Schillaci G, Mannarino E (2002) Blood rheology in men with essential hypertension and capillary rarefaction. J Hum Hypertens 16:533–537

    Article  CAS  PubMed  Google Scholar 

  4. Ferrara N, Davis-Smyth T (1997) The biology of vascular endothelial growth factor. Endocr Rev 18:4–25

    Article  CAS  PubMed  Google Scholar 

  5. Khakoo AY, Finkel T (2005) Endothelial progenitor cells. Annu Rev Med 56:79–101

    Article  CAS  PubMed  Google Scholar 

  6. Coban E, Timurağaoğlu A, Ozdoğan M (2004) Endothelial dysfunction in patients with white coat hypertension. J Hum Hypertens 18:71–72

    Article  CAS  PubMed  Google Scholar 

  7. Mandraffino G, Sardo MA, Riggio S, Loddo S, Imbalzano E, Alibrandi A, Saitta C, Cinquegrani M, Mormina EM, Saitta A (2011) Circulating progenitor cells are increased in newly diagnosed untreated hypertensive patients with arterial stiffening but normal carotid intima-media thickness. Hypertens Res 34:876–883

    Article  CAS  PubMed  Google Scholar 

  8. Palmirotta R, Ferroni P, Ludovici G, Martini F, Savonarola A, D’Alessandro R, Raparelli V, Proietti M, Scarno A, Riondino S, Basili S, Guadagni F (2010) VEGF-A gene promoter polymorphisms and microvascular complications in patients with essential hypertension. Clin Biochem 43:1090–1095

    Article  CAS  PubMed  Google Scholar 

  9. Hamedian AA, Esteghamati A, Noshad S, Mozafari M, Moin-Tavakkoli H, Nakhjavani M, Mahmoudi T, Nikzamir M, Safary R, Nikzamir A (2012) Vascular endothelial growth factor (VEGF) +405 C/G polymorphism is associated with essential hypertension in a population from Tehran of Iran. Mol Biol Rep 39:6213–6218

    Article  CAS  PubMed  Google Scholar 

  10. Rajnoch J, Viklický O (2004) Angiogenesis and organ transplantation. Folia Microbiol (Praha) 49:499–505

    Article  CAS  Google Scholar 

  11. Reiterová J, Obeidová H, Lenícek M, Stekrová J, Merta M, Maixnerová D, Vítek L, Viklický O, Tesar V (2008) Influence of VEGF polymorphism on progression of autosomal dominant polycystic kidney disease. Kidney Blood Press Res 31:398–403

    Article  PubMed  Google Scholar 

  12. Yang JW, Hutchinson IV, Shah T, Fang J, Min DI (2011) Gene polymorphism of vascular endothelial growth factor −1154 G > A is associated with hypertensive nephropathy in a Hispanic population. Mol Biol Rep 38:2417–2425

    Article  CAS  PubMed  Google Scholar 

  13. Lee S-H, Jeung IC, Park TW, Lee K, Lee DG, Cho Y-L, Lee TS, Na H-J, Park Y-J, Lee HG, Jeong MS, Bae K-H, Lee SC, Lee HJ, Kwon Y-G, Hong HJ, Kim J-S, Min J-K (2015) Extension of the in vivo half-life of endostatin and its improved anti-tumor activities upon fusion to a humanized antibody against tumor-associated glycoprotein 72 in a mouse model of human colorectal carcinoma. Oncotarget 6:7182–7194

    Article  PubMed  PubMed Central  Google Scholar 

  14. Skrzypkowska M, Myśliwska J, Słomiński B, Siebert J, Gutknecht P, Ryba-Stanisławowska M (2014) Quantitative and functional characteristics of endothelial progenitor cells in newly diagnosed hypertensive patients. J Hum Hypertens. doi:10.1038/jhh.2014.85

    PubMed  Google Scholar 

  15. Zhang K, Yin F, Lin L (2014) Circulating endothelial cells and chronic kidney disease. Biomed Res Int 2014:364738

    PubMed  PubMed Central  Google Scholar 

  16. Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, Albus C, Benlian P, Boysen G, Cifkova R, Deaton C, Ebrahim S, Fisher M, Germanò G, Hobbs R, Hoes A, Karadeniz S, Mezzani A, Prescott E, Ryden L, Scherer M, Syvanne M, Scholte Op Reimer WJM, Vrints C, Wood D, Zamorano JL, Zannad F (2012) Guidelines on cardiovascular disease prevention in clinical practice: the fifth joint task force of the european society of cardiology and other societies on cardiovascular disease prevention in clinical practice constituted by re. Eur Heart J 2012(33):1635–1701

    Google Scholar 

  17. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med 130:461–470

    Article  CAS  PubMed  Google Scholar 

  18. Mula-Abed W-AS, Al-Rasadi K, Al-Riyami D (2012) Estimated glomerular filtration rate (egfr): a serum creatinine-based test for the detection of chronic kidney disease and its impact on clinical practice. Oman Med J 27:108–113

    Article  PubMed  PubMed Central  Google Scholar 

  19. Kirsztajn GM, Filho NS, Draibe SA, de Netto MVP, Thomé FS, Souza E, Bastos MG (2012) Fast reading of the KDIGO guidelines for evaluation and management of chronic kidney disease in clinical practice. J Bras Nefrol'orgão Of Soc Bras e Lat-Am Nefrol 36:63–73

    Google Scholar 

  20. Rodríguez-Carrio J, de Paz B, López P, Prado C, Alperi-López M, Ballina-García FJ, Suárez A (2014) IFNα serum levels are associated with endothelial progenitor cells imbalance and disease features in rheumatoid arthritis patients. PLoS One 9:e86069

    Article  PubMed  PubMed Central  Google Scholar 

  21. Summers AM, Coupes BM, Brennan MF, Ralph SA, Short CD, Brenchley PEC (2005) VEGF -460 genotype plays an important role in progression to chronic kidney disease stage 5. Nephrol Dial Transplant 20:2427–2432

    Article  CAS  PubMed  Google Scholar 

  22. Chen J, Hamm LL, Kleinpeter MA, Husserl F, Khan IE, Chen C-S, Liu Y, Mills KT, He C, Rifai N, Simon EE, He J (2012) Elevated plasma levels of endostatin are associated with chronic kidney disease. Am J Nephrol 35:335–340

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Zhai Y-L, Zhu L, Shi S-F, Liu L-J, Lv J-C, Zhang H (2014) Elevated soluble VEGF receptor sFlt-1 correlates with endothelial injury in IgA nephropathy. PLoS ONE 9:e101779

    Article  PubMed  PubMed Central  Google Scholar 

  24. Domingueti CP, Dusse LM, Fóscolo RB, Reis JS, Annichino-Bizzacchi JM, Orsi FL, Mazetto Bde M, Carvalho Md, Gomes KB, Fernandes AP (2015) Von Willebrand Factor, ADAMTS13 and d-dimer are correlated with different levels of nephropathy in type 1 diabetes mellitus. PLoS One 10:e0132784

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

The paper was subsided by the grant of National Science Centre Nr 2011/01/B/NZ5/00345.

Author information

Authors and Affiliations

  1. Department of Immunology, Medical University of Gdańsk, 80-211, Gdańsk, Poland

    Anna Małkiewicz, Maria Skrzypkowska, Bartosz Słomiński & Jolanta Myśliwska

  2. Department of Family Medicine, Medical University of Gdańsk, 80-210, Gdańsk, Poland

    Janusz Siebert & Piotr Gutknecht

Authors
  1. Anna Małkiewicz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maria Skrzypkowska
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bartosz Słomiński
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Janusz Siebert
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Piotr Gutknecht
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jolanta Myśliwska
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anna Małkiewicz.

Ethics declarations

Conflict of interest

The authors declare that there are no conflicts of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Małkiewicz, A., Skrzypkowska, M., Słomiński, B. et al. The GG genotype of the −152 G/A vascular endothelial growth factor (VEGF) polymorphism predisposes to hypertension-related chronic kidney disease. Mol Biol Rep 43, 967–975 (2016). https://doi.org/10.1007/s11033-016-4035-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-016-4035-6

Keywords

Search

Navigation